Expand MOR Menu
MOR MENU

MOR Latest Press Releases

-- April 29, 2024 --

MorphoSys AG Reports First Quarter 2024 Financial Results Business Wire 4:01 PM

-- April 11, 2024 --

MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis ACCESSWIRE 9:01 AM
MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis Business Wire 8:39 AM

-- March 22, 2024 --

MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act ACCESSWIRE 2:51 AM

-- March 13, 2024 --

MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update Business Wire 4:02 PM

-- March 7, 2024 --

Invitation to MorphoSys' Full Year Results 2023 Conference Call on March 14, 2024 ACCESSWIRE 4:20 PM

-- February 5, 2024 --

MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for 2.7 Billion Equity Value ACCESSWIRE 5:17 PM
Incyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab (Monjuvi) Business Wire 4:46 PM

-- January 30, 2024 --

MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability ACCESSWIRE 3:16 AM

-- January 8, 2024 --

MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference ACCESSWIRE 2:21 AM

-- December 10, 2023 --

MorphoSys' Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study Business Wire 7:31 PM